Chemical | 20 July 2021
Balaxi Pharmaceuticals Q1 revenue increases by 12%
The company has reported PAT of Rs. 10.7 crore for Q1 FY22, higher by 23% YoY
The company has reported PAT of Rs. 10.7 crore for Q1 FY22, higher by 23% YoY
Company reported net sales of $4.4 billion, approximately 45% higher than the prior year, Selling prices increased by 3.5% and sales volumes were higher by approximately 24% in comparison to the previous year
Trinseo anticipates the transaction will close by year-end 2021 subject to customary closing conditions and regulatory approvals
As part of the joint venture, SK materials will invest $52 million in the development of a battery materials manufacturing hub in South Korea expected to launch in 2022
The increase will result from the relocation of its production site from Suzhou to Ningbo, China, which is scheduled to be completed by the end of 2021
With battery capacity of 3.24 KWh these incentives for Revolt bikes work out to Rs. 10,690 per bike. This includes a refund of State GST amounting to 2.5% of the vehicle cost
He has worked as director of Strategy and Corporate Development, leading several major strategy and M&A efforts and director of Global Specialty Solutions where he had led the company's high growth non-crop business
As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies
Company is building its second European plant in Komárom, Hungary, with an annual production capacity of about 10 gigawatt hours
The business provides flavors and flavor technologies to the food, beverage, and nutraceutical markets
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
Second-quarter net income was USD 539 million (USD 2.10 per share) compared with USD 223 million (USD 0.83 per share) a year earlier
Encourage automobile users of electric cars to recharge their batteries using renewable energy or solar energy during day hours
Pandemic has further widened the well-established social responsibility initiatives of both Deepak Group and its CSR arm, Deepak Foundation
The objective of the purchase of the shares of RPCPPL is to consolidate the shareholding of the company in RPCPPL.
As per the agreement and subject to customary closing conditions, Rossari will be acquiring 100% of the equity share capital of Tristar Intermediates
This drive supported all permitted age groups and some people with disabilities.
Growing R&D budgets of global pharmaceutical companies is the opportunity that Veeda and Bioneeds expect to capitalise on.
MCC is developing multiple new carbon fiber-related products that can meet the diversified and sophisticated needs of our customers.
The company has consistently invested in R&D capabilities and technologies
Subscribe to our newsletter & stay updated.
